Soluble TNF receptors release by polymorphonuclear cells and the serum levels in breast cancer patients before and after treatment

Neoplasma

Volumn 45, Issue 1, 1998, Pages 17-20

  JabLonska E ^a   Kiluk, M ^b   Markiewicz, W ^b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Center of Oncology   (Poland)

Author keywords

Soluble TNF receptor p55; Soluble TNF receptor p75; TNF

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; REGULATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; POLYMORPHONUCLEAR CELL;

EID: 0031972185     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. ABE, Y., OSUKA, Y, NAKATA, T., KASHU, Y., KIMURA, S.H.: The functional role of 55- and 75-kDa tumor necrosis factor receptors in human polymorphonuclear cells in vitro. Cytokine, 7, 1995, 39-49.
2. ALTSTAEDT, J., KIRCHNER, H., RINK, L.: Cytokine production of neutrophils is limited to interleukin-8. Immunology, 89, 1996, 563-568.
3. BEMELMANS, M.H.A., GOUMA, D.J., BUURMAN, W.A.: LPS-induced sTNF-receptor release in vivo in a murine model. J. Immunol., 151, 1993, 5554-5562.
4. BEMELMANS, M.H.A., ABRAMOWICZ, D., GOUMA, D.J., GOLDMAN, M., BUURMAN, W.A.: In vivo T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice. J. Immunol., 153, 1994, 499-506.
5. BELLDEGRUN, A., PIERCE, W., SAYAH, D., KERNION, J., WALLACH, D., ADERKA, D., FIGLIN, R.A.: Soluble tumor necrosis factor receptor expression in patients with metastatic renal cell carcinoma treated with interleukin-2-based immunotherapy. J.Immunother., 13, 1993, 175-180.
6. COPE, A.P., ADERKA, D., WALLACH, D., KAHAN, M., CHU, N.R., BRENNAN, F.M., FELDMAN, M.: Soluble TNF receptor production by activated T lymphocytes: Differential effects of acute and chronic exposure to TNF. Immunology, 84, 1995, 21-30.
7. GROSEN, E.A., YAMAOTO, R.S., IOLI, G., ININNS, G., GATANGA, M., GATANGA, T., DISAIA, P.J., BERMAN, M., MANETTA, A., GRANGER, G.A.: Blocking factors (soluble membrane receptors) for tumor necrosis factor and lymphotoxin detected in ascites and released in short-term cultures obtained from ascites and solid tumors in women with gynecologic malignancy. Lymphokine Cytokine Res., 11, 1992, 347-353.
8. HANNA, M.G., BUCANA, D.G., POLLACK, V.A.: Immunologic stimulation in situ: The acute and chronic inflammatory responses in the induction of tumor immunity. Contemp. Top. Immunobiol., 10, 1980, 267-296.
9. HELLER, R.A., KRONKE, M.; Tumor necrosis factor receptor-mediated signaling pathways. J. Cell Biol., 1, 1994, 5-9.
10. JOYCE, D.A., STEER, J.H.: IL-4, IL-10 and IFN-γ have distinct, but interacting effects on differentiation-induced changes in TNF-α and TNF receptor release by cultured human monocytes. Cytokine, 8, 1996, 49-57.
11. JABLOŃSKA, E., PIETRUSKLA, Z., KOZLOWSKI, M., FURMAN, M.: Serum levels of soluble interleukin-2 and soluble tumor necrosis factor receptor in patients with esophageal carcinoma. Dis. Esophagus, 9, 1996, 202-206.
12. LEEUWENBERG, J.F.M., JEUNHOMME, T.M.A.A., BUURMAN, W.A.: Slow release of soluble TNF receptors by monocytes in vitro. J. Immunol., 152, 1994, 4036-4043.
13. Pou., T., CALVANO, S.E., KUMAR, A., BRAXTON, C.C., COYLE, S.M., BARBOSA, K., MOLDAWER, L.L., LOWRY, S.F.: Endotoxin induces downregulation of tumor necrosis factor receptors on circulating monocytes and granulocytes in humans. Blood, 86, 1995, 2754-2759.
14. POLLMACHER, T., KORTH, C., MULLINGTON, J., SCHREIBER, W., SAUER, J., VEDDER, H., GALANOS, C., HOLSBOER, F.: Effects of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men. Blood, 87, 1996, 900-905.
15. PORTEU, F., BROCHAUS, M., WALLACH, D., ENGELMAN, H., NATHAN, C.F.: Human neutrophil elastase releases a ligand-binding fragment from the 75-kDa tumor necrosis factor (TNF) receptor. J. Biol. Chem., 266, 1991, 18 846-18 853.
16. STEINSHAM, S., BEMELMANS, M.H.A., BUURMAN, W., WAAGE, A.: Granulocytopenia reduces release of soluble TNF receptor p75 in endotoxin-stimulated mice: A possible mechanism of enhanced TNF activity. Cytokine, 7, 1995, 50-56.
17. STOPACCLARO, A., MELANI, C., PARENZA, M., MASTRACCHIO, A., BASSI, C., BARONI, C., PARMIANI, G., COLOMBO, M.P.: Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyteT cell cooperation and T cell-produced interferon gamma. J. Exp. Med, 1, 1993, 151-161.
18. TRENTIN, L, PIZZOLO, G., ZAMBELLO, R., AGOSTINI, C., MOROSATO, L.,SANCETTA, R., ADAMI, F., VINANTE,F., CHILOSI, M., GALLATI, H.: Leukemic cells in hairy cell leukemia and B cell chronic lymphocytic leukemia release soluble TNF receptors. Leukemia, 9, 1995, 1051-1055.